Scientific work

Prof. Dr. Leylagül Kaynar

573 publications. The source of the information is stated next to each publication.

Back to profile

  1. Is CMV PCR Monitoring Necessary for Hematological Malignancy During Chemotherapy? A Prospective Single-Center Study

    Turkish Journal of Hematology, 2026

    DOI 10.4274/tjh.galenos.2026.05743 PMID 42126222 2 citations (Europe PMC) Open-access full textSource: OpenAlex

  2. Antiviral drug resistance in cytomegalovirus complicating hematopoietic stem cell transplantation: prevalence, genotypic analysis and novel UL97/UL54 variants

    Journal of Chemotherapy, 2026

    DOI 10.1080/1120009x.2026.2643053 PMID 41834339 1 citation (Europe PMC) Source: OpenAlex

  3. Early-onset VEXAS syndrome mimicking orbital cellulitis and successfully treated with allogeneic hematopoietic stem cell transplantation

    Journal of Hematopathology, 2026

    DOI 10.1007/s12308-026-00741-2 PMID 42836952 Source: OpenAlex

  4. Universal Use of Novel Oral Anticoagulant Prophylaxis in Myeloma Patients Undergoing IMiD-Based Therapy: Real-World Experience

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15020453 PMID 41598391 2 citations (Europe PMC) Open-access full textSource: OpenAlex

  5. Temporal dynamics and predictors of carbapenem-resistant gram-negative bacteria in bloodstream infections in hematological patients

    BMC Infectious Diseases, 2026

    DOI 10.1186/s12879-026-13082-3 PMID 41820858 Open-access full textSource: OpenAlex

  6. Venetoclax-based treatment in adult relapsed/refractory acute lymphoblastic leukemia and lymphoblastic lymphoma: a single-center real-world experience

    Journal of Health Sciences and Medicine, 2026

    DOI 10.32322/jhsm.1825832 Open-access full textSource: OpenAlex

  7. Cardio-Hematology Crossroads: A Diffuse Large B-Cell Lymphoma Case Presenting with a Cardiac Mass

    The European Research Journal, 2026

    DOI 10.18621/eurj.1844523 Open-access full textSource: OpenAlex

  8. Incidence and outcome of hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: a survey of the infectious diseases working party of EBMT

    Bone Marrow Transplantation, 2026

    DOI 10.1038/s41409-026-02832-1 PMID 41888297 Source: OpenAlex

  9. Long-Term Complete Remission Following Lenalidomide-Augmented IVAC/ICE Therapy and Allogeneic Hematopoietic Stem Cell Transplantation in Hepatosplenic T-Cell Lymphoma: A Case Report

    Turkish Journal of Hematology, 2026

    DOI 10.4274/tjh.galenos.2026.13284 PMID 41914439 Open-access full textSource: OpenAlex

  10. Rifaximin Versus Levofloxacin: A Comparative Analysis of Prophylactic Efficacy in Allogeneic Stem Cell Transplantation

    Transplantation Proceedings, 2026

    DOI 10.1016/j.transproceed.2026.03.015 PMID 42002485 Source: OpenAlex

  11. Real-World Experience with Belinostat in the Treatment of Relapsed/Refractory Peripheral T-Cell Lymphoma

    Annals of Medical Research, 2026

    DOI 10.5455/annalsmedres.2025.07.193 Open-access full textSource: OpenAlex

  12. Direct Second Autologous Stem Cell Transplantation Versus Re-Induction Followed by Transplantation in Relapsed Multiple Myeloma: A Multicenter Real-World Study

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15135045 PMID 42452507 Open-access full textSource: OpenAlex

  13. A Multi-Targeted Strategy for Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: Real-World Outcomes of the ViPOR Regimen

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15145401 PMID 42513315 Open-access full textSource: OpenAlex

  14. Enterovirus Encephalitis Developing After Treatment for Follicular Lymphoma: A Case Report

    SN Comprehensive Clinical Medicine, 2026

    DOI 10.1007/s42399-026-02560-z Source: OpenAlex

  15. Evaluation of the frequency, risk factors, and outcomes of splanchnic vein thrombosis in myeloproliferative neoplasms: a retrospective cohort study

    Journal of Thrombosis and Thrombolysis, 2026

    DOI 10.1007/s11239-026-03363-8 PMID 42565930 Open-access full textSource: OpenAlex

  16. Real-World Effectiveness and Renal Safety of Foscarnet for CMV Reactivation After Allogeneic Hematopoietic Stem Cell Transplantation

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15166365 PMID 42652768 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  17. Foscarnet use in cytomegalovirus reactivation following hematopoietic stem cell transplantation — preliminary analysis of a single-center experience

    2026

    DOI 10.13140/rg.2.2.18387.34084 Source: OpenAlex

  18. The Damage Caused by the COVID-19 Pandemic to the Jacie Accredited Apheresis Unit and its Implications

    Nigerian Journal of Clinical Practice, 2026

    DOI 10.4103/njcp.njcp_709_25 PMID 42671446 Open-access full textSource: OpenAlex

  19. A complete response with daratumumab, venetoclax, azacitidine and dexamethasone in a heavily pre-treated, chemo-refractory early T-precursor acute lymphoblastic leukemia/lymphoma patient

    Annals of Hematology, 2025

    DOI 10.1007/s00277-024-06118-8 PMID 39847114 1 citation (Europe PMC) Source: OpenAlex

  20. The efficacy and safety of therapeutic thrombocytapheresis in patients with extreme thrombocytosis

    Transfusion Medicine, 2025

    DOI 10.1111/tme.13150 PMID 40387274 1 citation (Europe PMC) Source: OpenAlex

  21. Comparative analysis of the nephrotoxicity of liposomal amphotericin B and amphotericin B lipid complex in hematological cancer patients: A multicenter retrospective study

    Revista Iberoamericana de Micología, 2025

    DOI 10.1016/j.riam.2025.04.003 PMID 40562586 3 citations (Europe PMC) Source: OpenAlex

  22. Real-World Outcomes of Antifungal Prophylaxis in Adult Acute Lymphoblastic Leukemia Patients: A Multicenter Comparison of the Use of Fluconazole and Micafungin

    Journal of Clinical Medicine, 2025

    DOI 10.3390/jcm14207294 PMID 41156164 Open-access full textSource: OpenAlex

  23. Long-Term Response to Single-Agent Lenalidomide in an Elderly Patient with Relapsed Hepatosplenic T-Cell Lymphoma

    Turkish Journal of Hematology, 2025

    DOI 10.4274/tjh.galenos.2025.2025.0252 PMID 40859640 Open-access full textSource: OpenAlex

  24. Acute Promyelocytic Leukemia in a Patient With Sickle Cell Hemoglobin D Disease: A Case Report

    Cureus, 2025

    DOI 10.7759/cureus.87513 PMID 40777672 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  25. When high dose methotrexate stops working, a successful bridge to transplant with TEDDI-R in a case of secondary CNS lymphoma

    Annals of Hematology, 2025

    DOI 10.1007/s00277-025-06285-2 PMID 40016397 Open-access full textSource: OpenAlex

  26. Utilization of Clinical Data and Evaluation of Biomarkers in the Investigation of Graft-Versus-Host Disease Outcomes

    Methods in molecular biology, 2025

    DOI 10.1007/978-1-0716-4430-0_3 PMID 40100593 Source: OpenAlex

  27. 344 | SERUM β2‐ MICROGLOBULIN LEVELS IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA: AN UNRECOGNIZED PROGNOSTIC FACTOR

    Hematological Oncology, 2025

    DOI 10.1002/hon.70094_344 Open-access full textSource: OpenAlex

  28. Myth or reality: Graft versus host disease after autologous hematopoietic cell transplantation, a multicentre experience

    Transplant Immunology, 2025

    DOI 10.1016/j.trim.2025.102286 PMID 40907722 Source: OpenAlex

  29. Real-Life Retrospective Turkiye Data of the De-Escalation of ABVD to AVD in Hodgkin Lymphoma: On Behalf of the TSH Turkish Lymphoma Study Group

    Journal of Clinical Medicine, 2025

    DOI 10.3390/jcm14196813 PMID 41095893 Open-access full textSource: OpenAlex

  30. Successful treatment of steroid-refractory gastrointestinal GVHD with ruxolitinib in a patient after autologous stem cell transplantation: a case report

    International Journal of Hematology, 2025

    DOI 10.1007/s12185-025-04073-2 PMID 41004031 Source: OpenAlex

  31. Relaps/refrakter akut lenfoblastik lösemi ve lenfoblastik lenfomada venetoklaks temelli tedavi: tek merkez gerçek yaşam deneyimi

    DergiPark (Istanbul University), 2025

    Source: OpenAlex

  32. MİYELOPROLİFERATİF NEOPLAZMLARDA SPLANKNİK VEN TROMBOZUNUN DEĞERLENDİRİLMESİ: THD KRONİK MİYELOSİTER LÖSEMİ VE KRONİK MİYELOPROLİFERATİF NEOPLAZMLAR VE HEMOSTAZ - TROMBOZ BİLİMSEL ALT KOMİTELERİ ÇOK MERKEZ ÇALIŞMASI

    Bursa Uludag University - AVESIS, 2025

    Source: OpenAlex

  33. MİYELOPROLİFERATİF NEOPLAZMLARDA SPLANKNİK VEN TROMBOZUNUN DEĞERLENDİRİLMESİ: THD KRONİK MİYELOSİTER LÖSEMİ VE KRONİK MİYELOPROLİFERATİF NEOPLAZMLAR VE HEMOSTAZ - TROMBOZ BİLİMSEL ALT KOMİTELERİ ÇOK MERKEZ ÇALIŞMASI

    Kocaeli Üniversitesi - AVESİS, 2025

    Source: OpenAlex

  34. Cutaneous cytomegalovirus infection: a case report

    Skin Health and Disease, 2025

    DOI 10.1093/skinhd/vzaf057 PMID 42222707 Open-access full textSource: OpenAlex

  35. Eltrombopag treatment in thrombocytopenia following hematopoietic stem cell transplantation: A multicenter real-world experience

    Leukemia Research, 2024

    DOI 10.1016/j.leukres.2024.107484 PMID 38520796 3 citations (Europe PMC) Source: OpenAlex

  36. Single agent vemurafenib or rituximab-vemurafenib combination for the treatment of relapsed/refractory hairy cell leukemia, a multicenter experience

    Leukemia Research, 2024

    DOI 10.1016/j.leukres.2024.107495 PMID 38599153 3 citations (Europe PMC) Source: OpenAlex

  37. Antifungal Prophylaxis and Treatment of Breakthrough Invasive Fungal Diseases in High-Risk Hematology Patients: A Prospective Observational Multicenter Study

    Indian Journal of Hematology and Blood Transfusion, 2024

    DOI 10.1007/s12288-024-01790-2 PMID 39917507 2 citations (Europe PMC) Open-access full textSource: OpenAlex

  38. Evaluation of HOTAIR, HOXD8, HOXD9, HOXD11 gene expression levels in Turkish patients with acute and chronic myeloid leukemia: A single center experience

    Cellular and Molecular Biology, 2024

    DOI 10.14715/cmb/2024.70.11.5 PMID 39707783 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  39. Atypical presentation of PJP: hypercalcemia and kidney injury in an allogeneic stem cell transplant recipient

    BMC Infectious Diseases, 2024

    DOI 10.1186/s12879-024-10074-z PMID 39448907 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  40. Get two with one: bevacizumab treatment in hereditary hemorrhagic telangiectasia with concomitant cirrhosis

    Journal of Current Hematology & Oncology Research, 2024

    DOI 10.51271/jchor-0030 Source: OpenAlex

  41. Efficacy of therapeutic plasma exchange in patients with Crimean-Congo hemorrhagic fever

    Journal of Critical Care, 2024

    DOI 10.1016/j.jcrc.2024.154697 Source: OpenAlex

  42. Does early granulocyte colony-stimulating factor administration in autologous peripheral blood stem cell transplantation shorten the duration of hospitalization in patients with multiple myeloma?

    Journal of Current Hematology & Oncology Research, 2024

    DOI 10.51271/jchor-0035 Source: OpenAlex

  43. The Predictors of COVID-19 Immunogenicity Elicited by Vaccines Against SARS-CoV-2 in Stem Cell Transplant Recipients

    Flora the Journal of Infectious Diseases and Clinical Microbiology, 2024

    DOI 10.5578/flora.202402994 Source: OpenAlex

  44. Follow-up of patients given isoniazid prophylaxis in multiple myeloma patients underwent autologous stem cell transplantation

    Journal of Current Hematology & Oncology Research, 2024

    DOI 10.51271/jchor-0040 Source: OpenAlex

  45. Original vs. Generic Plerixafor for the Mobilization of Stem Cells in Multiple Myeloma Patients

    Indian Journal of Hematology and Blood Transfusion, 2024

    DOI 10.1007/s12288-024-01841-8 PMID 39917490 Open-access full textSource: OpenAlex

  46. CT-175 The Impact of Diabetes Mellitus on Hematopoietic Stem Cell Mobilization

    Clinical Lymphoma Myeloma & Leukemia, 2024

    DOI 10.1016/s2152-2650(24)01745-2 Source: OpenAlex

  47. MPN-231 Rare Anti-M Alloantibody Positivity in a Pregnant Woman and the Effectiveness of Plasmapheresis in Treatment: A Case Report

    Clinical Lymphoma Myeloma & Leukemia, 2024

    DOI 10.1016/s2152-2650(24)01415-0 Source: OpenAlex

  48. The Impact of Diabetes Mellitus on Hematopoietic Stem Cell Mobilization

    Clinical Lymphoma Myeloma & Leukemia, 2024

    DOI 10.1016/s2152-2650(24)01030-9 Source: OpenAlex

  49. A Case of Rapidly Progressing Tumoral Stage Mycosis Fungoides

    Turkish Journal of Hematology, 2024

    DOI 10.4274/tjh.galenos.2024.2024.0298 PMID 39552244 Open-access full textSource: OpenAlex

  50. Is CMV PCR Monitoring Necessary for Hematological Malignancy during Chemotherapy?

    Blood, 2024

    DOI 10.1182/blood-2024-193716 Open-access full textSource: OpenAlex